Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAFF
|
ENSG00000185022.7 | MAF bZIP transcription factor F |
MAFG
|
ENSG00000197063.6 | MAF bZIP transcription factor G |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr22_38616858_38617009 | MAFF | 7391 | 0.115580 | -0.47 | 2.0e-01 | Click! |
chr22_38613940_38614323 | MAFF | 4589 | 0.130650 | 0.46 | 2.1e-01 | Click! |
chr22_38599321_38599536 | MAFF | 401 | 0.754404 | -0.45 | 2.3e-01 | Click! |
chr22_38614803_38615828 | MAFF | 5773 | 0.122199 | -0.45 | 2.3e-01 | Click! |
chr22_38614387_38614538 | MAFF | 4920 | 0.127764 | 0.43 | 2.5e-01 | Click! |
chr17_79884292_79884443 | MAFG | 1217 | 0.157577 | -0.75 | 1.9e-02 | Click! |
chr17_79884635_79884786 | MAFG | 874 | 0.224290 | -0.72 | 3.0e-02 | Click! |
chr17_79882859_79883426 | MAFG | 1734 | 0.110119 | -0.62 | 7.3e-02 | Click! |
chr17_79884017_79884248 | MAFG | 1452 | 0.130567 | -0.37 | 3.3e-01 | Click! |
chr17_79881653_79881920 | MAFG | 378 | 0.544473 | 0.22 | 5.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_23188811_23189024 | 1.05 |
LOXL2 |
lysyl oxidase-like 2 |
2091 |
0.26 |
chr10_134224918_134226015 | 1.03 |
PWWP2B |
PWWP domain containing 2B |
14764 |
0.17 |
chr3_137762283_137762711 | 0.97 |
DZIP1L |
DAZ interacting zinc finger protein 1-like |
23985 |
0.17 |
chr14_23316976_23317711 | 0.97 |
ENSG00000212335 |
. |
4594 |
0.09 |
chr17_18124522_18124714 | 0.93 |
LLGL1 |
lethal giant larvae homolog 1 (Drosophila) |
4283 |
0.13 |
chr2_43152306_43152732 | 0.91 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
132787 |
0.05 |
chr8_121665009_121665299 | 0.90 |
RP11-713M15.1 |
|
108339 |
0.07 |
chr7_41476940_41477237 | 0.88 |
INHBA-AS1 |
INHBA antisense RNA 1 |
256426 |
0.02 |
chr1_22227763_22227914 | 0.87 |
HSPG2 |
heparan sulfate proteoglycan 2 |
5035 |
0.2 |
chr1_25041925_25042190 | 0.87 |
CLIC4 |
chloride intracellular channel 4 |
29791 |
0.15 |
chr1_10519294_10519577 | 0.87 |
RP5-1113E3.3 |
|
823 |
0.46 |
chr4_22387655_22387806 | 0.87 |
ENSG00000238383 |
. |
36657 |
0.21 |
chr15_40384302_40384677 | 0.84 |
RP11-521C20.3 |
|
3456 |
0.2 |
chr10_133760189_133760615 | 0.83 |
PPP2R2D |
protein phosphatase 2, regulatory subunit B, delta |
6869 |
0.26 |
chr2_20366034_20366185 | 0.83 |
ENSG00000266059 |
. |
8998 |
0.18 |
chr5_9048002_9048358 | 0.83 |
ENSG00000266415 |
. |
5827 |
0.3 |
chr12_66393056_66393407 | 0.83 |
RP11-366L20.3 |
|
50972 |
0.12 |
chr7_28523194_28523485 | 0.82 |
CREB5 |
cAMP responsive element binding protein 5 |
7409 |
0.33 |
chr5_10310434_10310794 | 0.82 |
CMBL |
carboxymethylenebutenolidase homolog (Pseudomonas) |
2476 |
0.19 |
chr2_47496531_47496728 | 0.80 |
EPCAM |
epithelial cell adhesion molecule |
75668 |
0.08 |
chr3_38871334_38871622 | 0.78 |
RP11-134J21.1 |
|
6085 |
0.2 |
chr5_148831707_148832136 | 0.77 |
ENSG00000269936 |
. |
21712 |
0.13 |
chr6_82724453_82724882 | 0.77 |
ENSG00000223044 |
. |
195490 |
0.03 |
chr2_28497749_28498516 | 0.76 |
AC093690.1 |
|
35194 |
0.19 |
chr8_12583575_12583726 | 0.75 |
ENSG00000266206 |
. |
1163 |
0.45 |
chr4_17060634_17060785 | 0.75 |
LDB2 |
LIM domain binding 2 |
160277 |
0.04 |
chr9_97787637_97787829 | 0.74 |
C9orf3 |
chromosome 9 open reading frame 3 |
20455 |
0.17 |
chr5_151119044_151119414 | 0.73 |
ATOX1 |
antioxidant 1 copper chaperone |
12450 |
0.14 |
chr3_42094281_42094623 | 0.73 |
TRAK1 |
trafficking protein, kinesin binding 1 |
38110 |
0.19 |
chr2_218296526_218296808 | 0.73 |
ENSG00000251982 |
. |
180388 |
0.03 |
chr11_121800095_121800514 | 0.73 |
ENSG00000252556 |
. |
74759 |
0.11 |
chr11_34066775_34067049 | 0.73 |
CAPRIN1 |
cell cycle associated protein 1 |
6318 |
0.27 |
chr8_49332411_49332756 | 0.72 |
ENSG00000252710 |
. |
111993 |
0.07 |
chr17_26673430_26673700 | 0.72 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
6133 |
0.07 |
chr10_49705076_49705298 | 0.72 |
ARHGAP22 |
Rho GTPase activating protein 22 |
3495 |
0.27 |
chr16_87245306_87245475 | 0.71 |
RP11-899L11.3 |
|
4131 |
0.26 |
chr4_140166524_140166675 | 0.71 |
ENSG00000206722 |
. |
11315 |
0.13 |
chr10_93221945_93222246 | 0.71 |
HECTD2 |
HECT domain containing E3 ubiquitin protein ligase 2 |
198 |
0.97 |
chr13_80509662_80509813 | 0.70 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
404057 |
0.01 |
chr4_8192745_8193409 | 0.70 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
8014 |
0.22 |
chr15_102215756_102215907 | 0.70 |
ENSG00000238502 |
. |
7887 |
0.16 |
chr11_122078494_122078645 | 0.69 |
ENSG00000207994 |
. |
55553 |
0.11 |
chr19_56645363_56645783 | 0.69 |
ZNF444 |
zinc finger protein 444 |
1605 |
0.26 |
chr1_233247855_233248191 | 0.69 |
PCNXL2 |
pecanex-like 2 (Drosophila) |
48030 |
0.19 |
chr15_63664697_63665270 | 0.69 |
CA12 |
carbonic anhydrase XII |
9051 |
0.26 |
chr1_201237669_201237867 | 0.69 |
PKP1 |
plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) |
14812 |
0.18 |
chrX_45481598_45481749 | 0.69 |
ENSG00000207870 |
. |
124021 |
0.06 |
chr2_12618919_12619301 | 0.69 |
ENSG00000207183 |
. |
67483 |
0.14 |
chr17_46044753_46045003 | 0.69 |
CDK5RAP3 |
CDK5 regulatory subunit associated protein 3 |
298 |
0.8 |
chr15_63664377_63664666 | 0.69 |
CA12 |
carbonic anhydrase XII |
9513 |
0.26 |
chr2_111223538_111223854 | 0.68 |
LIMS3 |
LIM and senescent cell antigen-like-containing domain protein 3; Uncharacterized protein; cDNA FLJ59124, highly similar to Particularly interesting newCys-His protein; cDNA, FLJ79109, highly similar to Particularly interesting newCys-His protein |
6697 |
0.18 |
chr4_114304726_114304877 | 0.68 |
ANK2 |
ankyrin 2, neuronal |
10286 |
0.22 |
chr14_51313483_51313634 | 0.68 |
RP11-218E20.2 |
|
1282 |
0.32 |
chr20_44409332_44409483 | 0.68 |
ENSG00000221046 |
. |
2070 |
0.17 |
chr4_170165351_170165677 | 0.68 |
SH3RF1 |
SH3 domain containing ring finger 1 |
25594 |
0.22 |
chr9_107592526_107592705 | 0.67 |
NIPSNAP3B |
nipsnap homolog 3B (C. elegans) |
66164 |
0.1 |
chr14_65273608_65273759 | 0.67 |
SPTB |
spectrin, beta, erythrocytic |
16129 |
0.19 |
chr20_4554675_4555120 | 0.67 |
PRNP |
prion protein |
111985 |
0.06 |
chr10_98783739_98783922 | 0.67 |
RP11-175O19.4 |
|
31623 |
0.16 |
chr11_95724685_95724836 | 0.67 |
MTMR2 |
myotubularin related protein 2 |
67301 |
0.13 |
chr16_20877808_20878174 | 0.67 |
DCUN1D3 |
DCN1, defective in cullin neddylation 1, domain containing 3 |
2311 |
0.25 |
chr6_16333896_16334190 | 0.67 |
ENSG00000265642 |
. |
94711 |
0.07 |
chr20_48568571_48568798 | 0.66 |
ENSG00000239157 |
. |
11747 |
0.13 |
chr1_186952299_186952611 | 0.66 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
154333 |
0.04 |
chr5_67629055_67629252 | 0.66 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
40757 |
0.21 |
chr8_96111972_96112794 | 0.66 |
RP11-320N21.2 |
|
12231 |
0.16 |
chr15_90205927_90206233 | 0.66 |
PLIN1 |
perilipin 1 |
4791 |
0.14 |
chr20_33895936_33896205 | 0.65 |
FAM83C |
family with sequence similarity 83, member C |
15866 |
0.1 |
chr11_86451585_86451736 | 0.65 |
PRSS23 |
protease, serine, 23 |
50441 |
0.16 |
chr14_55077952_55078103 | 0.65 |
SAMD4A |
sterile alpha motif domain containing 4A |
43390 |
0.17 |
chr3_10399626_10399784 | 0.65 |
ENSG00000264534 |
. |
27792 |
0.11 |
chr21_32574317_32574611 | 0.65 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
71925 |
0.12 |
chr1_68261182_68261333 | 0.65 |
ENSG00000238778 |
. |
22921 |
0.18 |
chr15_68676145_68676296 | 0.64 |
ITGA11 |
integrin, alpha 11 |
48272 |
0.16 |
chr2_74791663_74791906 | 0.64 |
LOXL3 |
lysyl oxidase-like 3 |
8967 |
0.09 |
chr1_39620254_39620593 | 0.64 |
ENSG00000222378 |
. |
455 |
0.82 |
chr11_75798073_75798350 | 0.64 |
UVRAG |
UV radiation resistance associated |
28746 |
0.17 |
chr22_30176990_30177141 | 0.64 |
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
13702 |
0.12 |
chr12_102288439_102288933 | 0.64 |
DRAM1 |
DNA-damage regulated autophagy modulator 1 |
13406 |
0.14 |
chr1_117395566_117395896 | 0.64 |
ENSG00000221425 |
. |
52041 |
0.12 |
chr17_41327708_41328475 | 0.64 |
NBR1 |
neighbor of BRCA1 gene 1 |
4831 |
0.16 |
chr8_23578215_23578506 | 0.64 |
RP11-175E9.1 |
|
13706 |
0.16 |
chr2_238107931_238108082 | 0.63 |
AC112715.2 |
Uncharacterized protein |
57728 |
0.13 |
chr20_3824293_3824586 | 0.63 |
MAVS |
mitochondrial antiviral signaling protein |
3048 |
0.18 |
chr11_130716718_130716869 | 0.63 |
SNX19 |
sorting nexin 19 |
46976 |
0.19 |
chr5_77887462_77888069 | 0.63 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
42791 |
0.21 |
chr3_170519523_170519674 | 0.63 |
ENSG00000222411 |
. |
40363 |
0.17 |
chr6_117816166_117816317 | 0.62 |
DCBLD1 |
discoidin, CUB and LCCL domain containing 1 |
12416 |
0.18 |
chr5_111341016_111341167 | 0.62 |
NREP |
neuronal regeneration related protein |
7930 |
0.25 |
chr2_43312926_43313185 | 0.62 |
ENSG00000207087 |
. |
5577 |
0.32 |
chr10_114718598_114718749 | 0.62 |
RP11-57H14.2 |
|
7039 |
0.23 |
chr6_83980864_83981015 | 0.62 |
PGM3 |
phosphoglucomutase 3 |
77284 |
0.09 |
chr16_82867074_82867225 | 0.62 |
ENSG00000221395 |
. |
8542 |
0.22 |
chr18_12278438_12278696 | 0.62 |
CIDEA |
cell death-inducing DFFA-like effector a |
24249 |
0.15 |
chr10_80944978_80945155 | 0.61 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
116274 |
0.06 |
chr18_457195_458136 | 0.61 |
RP11-720L2.2 |
|
33249 |
0.16 |
chr8_125827870_125828161 | 0.61 |
ENSG00000263735 |
. |
6285 |
0.28 |
chr10_68587002_68587153 | 0.61 |
LRRTM3 |
leucine rich repeat transmembrane neuronal 3 |
98687 |
0.09 |
chr14_62030760_62030911 | 0.61 |
RP11-47I22.3 |
Uncharacterized protein |
6479 |
0.21 |
chr6_114316389_114316540 | 0.61 |
RP3-399L15.3 |
|
56 |
0.98 |
chr5_14806397_14806548 | 0.61 |
ENSG00000264792 |
. |
19649 |
0.23 |
chr7_134938990_134939625 | 0.61 |
STRA8 |
stimulated by retinoic acid 8 |
22576 |
0.17 |
chr6_128922444_128922595 | 0.60 |
ENSG00000238938 |
. |
11827 |
0.2 |
chr7_151345468_151345619 | 0.60 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
15292 |
0.24 |
chr7_80128841_80128992 | 0.60 |
GNAT3 |
guanine nucleotide binding protein, alpha transducing 3 |
12420 |
0.28 |
chr4_77876332_77876483 | 0.60 |
SEPT11 |
septin 11 |
5392 |
0.26 |
chr14_100275563_100275795 | 0.60 |
EML1 |
echinoderm microtubule associated protein like 1 |
109 |
0.98 |
chr17_54370077_54370228 | 0.60 |
ANKFN1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
118616 |
0.06 |
chr7_98047722_98048054 | 0.59 |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
17508 |
0.24 |
chr6_163776181_163776490 | 0.59 |
QKI |
QKI, KH domain containing, RNA binding |
59340 |
0.15 |
chr11_33958949_33959310 | 0.59 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
45293 |
0.15 |
chr6_15133584_15133823 | 0.59 |
ENSG00000264687 |
. |
16327 |
0.22 |
chr11_12790880_12791164 | 0.59 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
24434 |
0.21 |
chr2_45908653_45909145 | 0.59 |
U51244.2 |
|
6284 |
0.25 |
chr11_114224456_114224725 | 0.59 |
RP11-64D24.2 |
|
2703 |
0.24 |
chr7_92645118_92645650 | 0.59 |
ENSG00000266794 |
. |
44771 |
0.17 |
chr3_123475857_123476473 | 0.59 |
MYLK |
myosin light chain kinase |
36523 |
0.15 |
chr13_98826079_98826230 | 0.59 |
RNF113B |
ring finger protein 113B |
3365 |
0.2 |
chr10_17028040_17028191 | 0.59 |
CUBN |
cubilin (intrinsic factor-cobalamin receptor) |
1921 |
0.47 |
chr6_138861196_138861347 | 0.59 |
NHSL1 |
NHS-like 1 |
5577 |
0.29 |
chr5_34683046_34683197 | 0.59 |
RAI14 |
retinoic acid induced 14 |
1502 |
0.48 |
chr2_20290862_20291052 | 0.58 |
RP11-644K8.1 |
|
39062 |
0.13 |
chr9_83264199_83264350 | 0.58 |
ENSG00000221581 |
. |
84970 |
0.11 |
chr3_12219398_12219941 | 0.58 |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
18818 |
0.25 |
chr17_19807679_19807830 | 0.58 |
RP11-209D14.4 |
|
25296 |
0.15 |
chr10_122215796_122216013 | 0.58 |
PPAPDC1A |
phosphatidic acid phosphatase type 2 domain containing 1A |
562 |
0.81 |
chr3_73607889_73608040 | 0.58 |
PDZRN3 |
PDZ domain containing ring finger 3 |
2805 |
0.33 |
chr1_163137592_163137743 | 0.57 |
RP11-267N12.1 |
|
6202 |
0.24 |
chr2_23641423_23641574 | 0.57 |
KLHL29 |
kelch-like family member 29 |
33410 |
0.23 |
chr14_51974464_51974948 | 0.57 |
ENSG00000252400 |
. |
14876 |
0.21 |
chr1_109934550_109935130 | 0.57 |
SORT1 |
sortilin 1 |
1139 |
0.45 |
chr14_68943525_68944196 | 0.57 |
RAD51B |
RAD51 paralog B |
65633 |
0.13 |
chr18_53068794_53069017 | 0.57 |
TCF4 |
transcription factor 4 |
16 |
0.98 |
chr13_21654649_21654800 | 0.57 |
LATS2 |
large tumor suppressor kinase 2 |
19038 |
0.14 |
chr7_92383033_92383210 | 0.57 |
ENSG00000206763 |
. |
51993 |
0.14 |
chr3_106530119_106530270 | 0.57 |
ENSG00000200361 |
. |
122669 |
0.06 |
chr9_110159635_110159786 | 0.56 |
ENSG00000263459 |
. |
36180 |
0.18 |
chr20_17631707_17631968 | 0.56 |
RRBP1 |
ribosome binding protein 1 |
9315 |
0.21 |
chr10_92502044_92502195 | 0.56 |
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
115336 |
0.06 |
chr19_17246413_17247205 | 0.56 |
CTD-3032J10.2 |
|
32048 |
0.08 |
chr1_214603566_214603717 | 0.56 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
34505 |
0.2 |
chr3_27368316_27368570 | 0.56 |
NEK10 |
NIMA-related kinase 10 |
35395 |
0.16 |
chr13_32339169_32339320 | 0.56 |
RXFP2 |
relaxin/insulin-like family peptide receptor 2 |
25565 |
0.27 |
chr6_57170948_57171315 | 0.56 |
PRIM2 |
primase, DNA, polypeptide 2 (58kDa) |
11291 |
0.25 |
chr6_85291342_85291495 | 0.56 |
RP11-132M7.3 |
|
107725 |
0.08 |
chr5_14178843_14178994 | 0.56 |
TRIO |
trio Rho guanine nucleotide exchange factor |
4989 |
0.36 |
chr6_82648031_82648424 | 0.55 |
ENSG00000206886 |
. |
174486 |
0.03 |
chr2_157393241_157393392 | 0.55 |
AC011308.1 |
|
40661 |
0.18 |
chr17_39216444_39216595 | 0.55 |
KRTAP2-3 |
keratin associated protein 2-3 |
175 |
0.84 |
chr17_75117278_75117429 | 0.55 |
SEC14L1 |
SEC14-like 1 (S. cerevisiae) |
6602 |
0.21 |
chr7_155005364_155005515 | 0.55 |
AC099552.4 |
Uncharacterized protein |
15293 |
0.2 |
chr6_42107733_42108095 | 0.55 |
C6orf132 |
chromosome 6 open reading frame 132 |
2268 |
0.24 |
chr11_72868697_72869453 | 0.55 |
FCHSD2 |
FCH and double SH3 domains 2 |
15769 |
0.19 |
chr6_52912558_52912828 | 0.55 |
FBXO9 |
F-box protein 9 |
4096 |
0.16 |
chr2_201231995_201232146 | 0.55 |
ENSG00000201649 |
. |
5828 |
0.2 |
chr14_33093084_33093235 | 0.55 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
111898 |
0.07 |
chr9_118135298_118135583 | 0.55 |
DEC1 |
deleted in esophageal cancer 1 |
231343 |
0.02 |
chr15_39649867_39650249 | 0.55 |
RP11-624L4.1 |
|
62852 |
0.14 |
chr7_132088234_132088385 | 0.55 |
AC011625.1 |
|
51216 |
0.17 |
chr13_76194393_76194544 | 0.55 |
LMO7 |
LIM domain 7 |
102 |
0.97 |
chr7_33912572_33912723 | 0.55 |
BMPER |
BMP binding endothelial regulator |
31876 |
0.24 |
chr8_16569803_16569954 | 0.55 |
MSR1 |
macrophage scavenger receptor 1 |
145007 |
0.05 |
chr10_77747509_77747660 | 0.55 |
ENSG00000221232 |
. |
139485 |
0.05 |
chr10_114891116_114891459 | 0.55 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
12392 |
0.3 |
chr6_71816469_71816811 | 0.55 |
ENSG00000221345 |
. |
20168 |
0.24 |
chr20_33114405_33114556 | 0.55 |
ENSG00000206582 |
. |
69 |
0.97 |
chr1_65636343_65636672 | 0.54 |
AK4 |
adenylate kinase 4 |
22621 |
0.21 |
chr6_134317387_134317538 | 0.54 |
TBPL1 |
TBP-like 1 |
43100 |
0.15 |
chr10_126835454_126835747 | 0.54 |
CTBP2 |
C-terminal binding protein 2 |
11685 |
0.28 |
chr3_99037843_99037994 | 0.54 |
ENSG00000266030 |
. |
47815 |
0.19 |
chrX_45211105_45211256 | 0.54 |
RP11-342D14.1 |
|
31477 |
0.25 |
chr10_79264730_79264881 | 0.54 |
ENSG00000199592 |
. |
82002 |
0.1 |
chr3_99346122_99346273 | 0.54 |
COL8A1 |
collagen, type VIII, alpha 1 |
11122 |
0.27 |
chr12_31645575_31645726 | 0.54 |
DENND5B |
DENN/MADD domain containing 5B |
3186 |
0.23 |
chr10_79291591_79291742 | 0.54 |
ENSG00000199592 |
. |
55141 |
0.15 |
chr15_60676986_60677137 | 0.54 |
ANXA2 |
annexin A2 |
6265 |
0.29 |
chr3_120180997_120181426 | 0.54 |
FSTL1 |
follistatin-like 1 |
11111 |
0.26 |
chr4_119687150_119687301 | 0.54 |
SEC24D |
SEC24 family member D |
3770 |
0.33 |
chr20_52354765_52355003 | 0.53 |
ENSG00000238468 |
. |
69587 |
0.12 |
chr4_54357004_54357155 | 0.53 |
LNX1-AS1 |
LNX1 antisense RNA 1 |
5488 |
0.26 |
chr2_151386213_151386364 | 0.53 |
RND3 |
Rho family GTPase 3 |
9237 |
0.33 |
chr9_113205503_113205654 | 0.53 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
15540 |
0.24 |
chr1_94795714_94796066 | 0.53 |
ABCD3 |
ATP-binding cassette, sub-family D (ALD), member 3 |
88043 |
0.08 |
chr8_108502262_108502496 | 0.53 |
ANGPT1 |
angiopoietin 1 |
4844 |
0.36 |
chr17_9273783_9274123 | 0.53 |
AC087501.1 |
|
81561 |
0.08 |
chr3_58948177_58948328 | 0.53 |
C3orf67 |
chromosome 3 open reading frame 67 |
24764 |
0.26 |
chr4_100326139_100326290 | 0.53 |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
25234 |
0.19 |
chr18_408091_408359 | 0.53 |
RP11-720L2.2 |
|
16191 |
0.23 |
chr5_38925164_38925315 | 0.53 |
OSMR |
oncostatin M receptor |
20739 |
0.26 |
chr5_97974235_97974386 | 0.53 |
ENSG00000223053 |
. |
625 |
0.83 |
chr1_145543600_145543751 | 0.52 |
RP11-315I20.3 |
|
1446 |
0.24 |
chr15_67006142_67006408 | 0.52 |
SMAD6 |
SMAD family member 6 |
2240 |
0.39 |
chr4_124339789_124340334 | 0.52 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
18938 |
0.3 |
chr2_239637776_239637927 | 0.52 |
TWIST2 |
twist family bHLH transcription factor 2 |
118822 |
0.06 |
chr14_73248175_73248326 | 0.52 |
ENSG00000206751 |
. |
71789 |
0.11 |
chr16_85429807_85430115 | 0.52 |
RP11-680G10.1 |
Uncharacterized protein |
38892 |
0.16 |
chr7_23387609_23387938 | 0.52 |
ENSG00000212264 |
. |
48292 |
0.12 |
chr3_141054328_141054622 | 0.52 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
11420 |
0.22 |
chr1_235984732_235984883 | 0.52 |
LYST-AS1 |
LYST antisense RNA 1 |
17976 |
0.17 |
chr2_145866803_145866954 | 0.52 |
ENSG00000253036 |
. |
225760 |
0.02 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.4 | GO:0021508 | floor plate formation(GO:0021508) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.4 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.2 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.3 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.2 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 0.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.2 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.2 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.1 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.1 | GO:0060841 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.2 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.0 | GO:2000647 | negative regulation of mesenchymal cell proliferation(GO:0072201) negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.2 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0060753 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.2 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.0 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.3 | GO:0010510 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.2 | GO:0090280 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.3 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.0 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0019098 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.0 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.2 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.2 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0048319 | axial mesoderm development(GO:0048318) axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.5 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.2 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 1.0 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.3 | 0.8 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.8 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.2 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.3 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.6 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.2 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.5 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.2 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 1.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 1.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.0 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 2.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |